These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 21634214)
1. [Epstein-Barr virus positive T/NK-cell lymphoproliferative disease: the pathogenesis and target cells of infection]. Ohga S Fukuoka Igaku Zasshi; 2011 Mar; 102(3):41-7. PubMed ID: 21634214 [No Abstract] [Full Text] [Related]
2. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Kimura H Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843 [TBL] [Abstract][Full Text] [Related]
8. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival. Imadome K; Shimizu N; Arai A; Miura O; Watanabe K; Nakamura H; Nonoyama S; Yamamoto K; Fujiwara S J Infect Dis; 2005 Oct; 192(8):1340-8. PubMed ID: 16170750 [TBL] [Abstract][Full Text] [Related]
9. Cutaneous lymphoproliferative disorder complicating infectious mononucleosis in an immunosuppressed patient. Owen CE; Callen JP; Bahrami S Pediatr Dermatol; 2011; 28(2):149-55. PubMed ID: 20497356 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338 [TBL] [Abstract][Full Text] [Related]
11. Haematological associations of Epstein-Barr virus infection. Okano M Baillieres Best Pract Res Clin Haematol; 2000 Jun; 13(2):199-214. PubMed ID: 10942621 [TBL] [Abstract][Full Text] [Related]
12. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis. Asada H; Miyagawa S; Sumikawa Y; Yamaguchi Y; Itami S; Suguri S; Harada M; Tokura Y; Ishihara S; Ohshima S; Yoshikawa K Arch Dermatol; 2003 Dec; 139(12):1601-7. PubMed ID: 14676078 [TBL] [Abstract][Full Text] [Related]
17. Infiltrations of Epstein-Barr virus-carrying cells in granular lymphocyte-proliferative disorders corresponding to chronic active Epstein-Barr virus infection. Takechi T; Maeda A; Hisakawa H; Wakiguchi H; Takeuchi T; Sonobe H; Ohtsuki Y Pediatr Hematol Oncol; 2002; 19(7):459-65. PubMed ID: 12217191 [TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection. Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706 [TBL] [Abstract][Full Text] [Related]
19. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients. Klein G; Purtilo D Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974 [No Abstract] [Full Text] [Related]
20. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Ohshima K; Kimura H; Yoshino T; Kim CW; Ko YH; Lee SS; Peh SC; Chan JK; Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]